Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 2, 2009, Pages 427-438

  Diotte, Nicole M ^a   Xiong, Ye ^a   Gao, Jinping ^b   Chua, Balvin H L ^b   Ho, Ye Shih ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b East Tennessee State University   (United States)

Author keywords

Cytochrome c; Mitochondria; Oxidative stress; Protein S glutathionylation; Transgenic mice

Indexed keywords

CREATINE KINASE; CYTOCHROME C; DISULFIDE; DOXORUBICIN; FLAVINE ADENINE NUCLEOTIDE; GLUTAREDOXIN; GLUTATHIONE; MITOCHONDRIAL PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEPTIDE; PROTEIN BID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; CATALYSIS; CIRCULATION; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; GENE OVEREXPRESSION; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HOMOGENATE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL RESPIRATION; CREATINE KINASE; CYTOCHROMES C; CYTOPROTECTION; DOXORUBICIN; FLAVIN-ADENINE DINUCLEOTIDE; GLUTAREDOXINS; GLUTATHIONE; HEART DISEASES; HUMANS; MICE; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; NAD; VENTRICULAR FUNCTION, LEFT;

MUS; MUS MUSCULUS;

EID: 58749103645     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.10.014     Document Type: Article

References (70)

1. Ferrans V.J. Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat. Rep. 62 (1978) 955-961
2. Shan K., Lincoff A.M., and Young J.B. Anthracycline-induced cardiotoxicity. Ann. Intern. Med. 125 (1996) 47-58
3. Bristow M.R., Thompson P.D., Martin R.P., Mason J.W., Billingham M.E., and Harrison D.C. Early anthracycline cardiotoxicity. Am. J. Med. 65 (1978) 823-832
4. Singal P.K., and Iliskovic N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339 (1998) 900-905
5. 2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the sidechain hydroxyl group. Biochem. Biophys. Acta 884 (1986) 326-336
6. Malisza K.L., and Hasinoff B.B. Production of hydroxyl radical by iron(III)-anthraquinone complexes through self-reduction and through reductive activation by the xanthine oxidase/hypoxanthine system. Arch. Biochem. Biophys. 321 (1995) 51-60
7. Doroshow J.H. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res. 43 (1983) 4543-4551
8. Davies K.J., and Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261 (1986) 3060-3067
9. Doroshow J.H., and Davies K.J. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261 (1986) 3068-3074
10. Bachur N.R., Gordon S.L., Gee M.V., and Kon H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 954-957
11. Vásquez-Vivar J., Martasek P., Hogg N., Masters B.B.S., Pritchard K.A., and Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from Adriamycin. Biochemistry 36 (1997) 11293-11297
12. Garner A.P., Paine M.J.I., Rodriguez-Crespo I., Chinje E.C., Oritz De Montellano P.O., Stratford I.J., Tew D.G., and Wolf C.R. Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents. Cancer Res. 59 (1999) 1929-1934
13. Praet M., Pollakis G., Goormaghtigh E., and Ruysschaert J.M. Damages of the mitochondrial membrane in adriamycin treated mice. Cancer Lett. 25 (1984) 89-96
14. Solem L.E., Henry T.R., and Wallace K.B. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol. Appl. Pharmacol. 129 (1994) 214-222
15. Santos D.L., Moreno A.J., Leino R.L., Froberg M.K., and Wallace K.B. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy. Toxicol. Appl. Pharmacol. 185 (2002) 218-227
16. Wallace K.B. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol. Toxicol. 93 (2003) 105-115
17. Green P.S., and Leeuwenburgh C. Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochim. Biophys. Acta 1588 (2002) 94-101
18. Ascensão A., Magalhaes J., Soares J.M., Ferreira R., Neuparth M.J., Marques F., Oliveira P.J., and Duarte J.A. Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am. J. Physiol.: Heart Circ. Physiol. 289 (2005) H722-H731
19. Oliveira P.J., Santos M.S., and Wallace K.B. Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration. Biochemistry (Mosc) 71 (2006) 194-199
20. Liu X., Chen Z., Chua C.C., Ma Y.S., Youngberg G.A., Hamdy R., and Chua B.H.L. Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am. J. Physiol.: Heart Circ. Physiol. 283 (2002) H254-H263
21. Siveski-Iliskovic N., Kaul N., and Singal P.K. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89 (1994) 2829-2835
22. Seifert C.F., Nesser M.F., and Thompson D.F. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity. Ann. Pharmacother. 28 (1994) 1063-1072
23. Samelis G.F., Stathopoulos G.P., Kotsarelis D., Dontas I., Frangia C., and Karayannacos P.E. Doxorubicin cardiotoxicity and serum lipid increase is prevented by dexrazoxane (ICRF-187). Anticancer Res. 18 (1998) 3305-3309
24. Nazeyrollas P., Prevost A., Baccard N., Manot L., Devillier P., and Millart H. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity. Cancer Chemother. Pharmacol. 43 (1999) 227-232
25. Yen H.C., Oberley T.D., Vichitbandha S., Ho Y.-S., and Clair St D.K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 98 (1996) 1253-1260
26. Kang Y.J., Chen Y., and Epstein P.N. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 271 (1996) 12610-12616
27. Xiong Y., Liu X., Lee C.P., Chua B.H.L., and Ho Y.-S. Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase. Free Radical Biol. Med. 41 (2006) 46-55
28. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
29. Pineda-Molina E., Klatt P., Vazquez J., Marina A., de Lacoba M.G., Perez-Sala D., and Lamas S. Glutathionylation of the p50 subunit of NF-κB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 40 (2001) 14134-14142
30. Bandyopadhyay S., Starke D.W., Mieyal J.J., and Gronostajski R.M. Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of oxidation-inactivated nuclear factor I. J. Biol. Chem. 273 (1998) 392-397
31. Barrett W.C., DeGnore J.P., Konig S., Fales H.M., Keng Y., Zhong-Yin Z., Yim M.B., and Chock P.B. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38 (1999) 6699-6705
32. Barrett W.C., DeGnore J.P., Keng Y., Zhang Z., Yim M.B., and Chock P.B. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J. Biol. Chem. 274 (1999) 34543-34546
33. Ward N.E., Stewart J.R., Ioannides C.G., O C.A., and ' Brian. Oxidant-induced S-glutathiolation inactivates protein kinase C-α (PKC-α): a potential mechanism of PKC isozyme regulation. Biochemistry 39 (2000) 10319-10329
34. Davis D.A., Newcomb F.M., Starke D.W., Ott D.E., Mieyal J.J., and Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol. Chem. 272 (1997) 25935-25940
35. Dafre A.L., Sies H., and Akerboom T. Protein S-thiolation and regulation of microsomal glutathione transferase activity by the glutathione redox couple. Arch. Biochem. Biophys. 332 (1996) 288-294
36. Adachi T., Pimentel D.R., Heibeck T., Hou X., Lee Y.L., Jiang B., Ido Y., and Cohen R.A. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 279 (2004) 29857-29862
37. Yang Y., Jao S., Nanduri S., Starke D.W., Mieyal J.J., and Qin J. Reactivity of the human thioltransferase (glutaredoxin) C7S, C25S, C78S, C82S mutant and NMR solution structure of its glutathionyl mixed disulfide intermediate reflect catalytic specificity. Biochemistry 37 (1998) 17145-17156
38. Wells W.W., Yang Y., Deits T.L., and Gan Z.R. Thioltransferases. Adv. Enzymol. Relat. Areas Mol. Biol. 66 (1993) 149-201
39. Lundberg M., Johansson C., Chandra J., Enoksson M., Jacobsson G., Ljung J., Johansson M., and Holmgren A. Cloning and expression of a novel human glutaredoxin (Grx2) mitochondrial and nuclear isoforms. J. Biol. Chem. 276 (2001) 26269-26275
40. Gladyshev V.N., Liu A., Novoselov S.V., Krysan K., Sun Q.A., Kryukov V.M., Kryukov G.V., and Lou M.F. Identification of a new mammalian glutaredoxin (thiotransferase), grx2. J. Biol. Chem. 276 (2001) 30374-30380
41. Lind S., Gerdes R., Schuppe-Koistinen I., and Cotgreave I.A. Studies on the mechanism of oxidative modification of human glyceraldehyde-3-phosphate dehydrogenase by glutathione: catalysis by glutaredoxin. Biochem. Biophys. Res. Commun. 247 (1998) 481-486
42. Starke D.W., Chock P.B., and Mieyal J.J. Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase): Potential role in redox signal transduction. J. Biol. Chem. 278 (2003) 14607-14613
43. Beer S.M., Taylor E.R., Brown S.E., Dahm C.C., Costa N.J., Runswick M.J., and Murphy M.P. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defense. J. Biol. Chem. 279 (2004) 47939-47951
44. Meyer E.B., and Wells W.W. Thiotransferase increases resistance of MCF-7 cells to adriamycin. Free Radical Biol. Med. 26 (1999) 770-776
45. Chrestensen C.A., Starke D.W., and Mieyal J.J. Acute cadmium exposure inactivates thioltransferase (Glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis. J. Biol. Chem. 275 (2000) 26556-26565
46. Daily D., Vlamis-Gardikas A., Offen D., Mittelman L., Melamed E., Holmgren A., and Barzilai A. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-κB via Ref-1. J. Biol. Chem. 276 (2001) 1335-1344
47. 2. J. Biol. Chem. 277 (2002) 46566-46577
48. Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J. Biol. Chem. 278 (2003) 50226-50233
49. Enoksson M., Fernandes A.P., Prast S., Lillig C.H., Holmgren A., and Orrenius S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem. Biophys. Res. Commun. 327 (2005) 774-779
50. Chen Z., Chua C.C., Ho Y.-S., Hamdy R.C., and Chua B.H.L. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am. J. Physiol.: Heart Circ. Physiol. 280 (2001) H2313-H2320
51. Subramaniam A., Jones W.K., Gulick J., Wert S., Neumann J., and Robbins J. Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266 (1991) 24613-24620
52. Hogan R., Constantini F., and Lacy E. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, (1986) 90-203
53. Thomas P.S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 5201-5205
54. Johansson C., Lillig C.H., and Holmgren A. Identification of a new mammalian glutaredoxin (thiotransferase), grx2. J. Biol. Chem. 279 (2004) 7537-7543
55. Little C., Olinescu R., Reid K.G., and O'Brien P.J. Properties and regulation of glutathione peroxidase. J. Biol. Chem. 245 (1970) 3632-3636
56. Hosova-Matsuda N., Motohashi K., Yoshimura H., Nozaki A., Inoue K., Ohmori M., and Hisabori T. Anti-oxidative stress system in cyanobacteria. Significance of type II peroxiredoxin and the role of 1-Cys peroxiredoxin in Synechocystis sp. strain PCC 6803. J. Biol. Chem. 280 (2005) 840-846
57. Kang Y.J., Zhou Z.-W., Wang G.-W., Buridi A., and Klein J.B. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J. Biol. Chem. 275 (2000) 13690-13698
58. Childs A., Phaneuf S.L., Dirks A.J., Phillips T., and Leeuwenburgh C. Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res. 62 (2002) 4592-4598
59. Nithipongvanitch R., Ittarat W., Velez J.M., Zhao R., Clair St. D.K., and Oberley T.D. Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment. J. Histochem. Cytochem. 55 (2007) 629-639
60. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481-490
61. Chaiswing L., Cole M.P., Clair St. D.K., Ittarat W., Szweda L.I., and Oberley T.D. Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury. Toxicol. Pathol. 32 (2004) 536-547
62. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
63. Malik G., Nogy N., Ho Y.-S., Maulik N., and Das D.K. Role of glutaredoxin-1 in cardioprotection: an insight with Glrx1 transgenic and knockout animals. J. Mol. Cell. Cardiol. 44 (2008) 261-269
64. Fernando M.R., Lechner J.M., Löfgren S., Gladyshev V.N., and Lou M.F. Mitochondrial thioltransferase (glutaredoxin 2) has GSH-dependent and thioredoxin reductase-dependent peroxidase activities in vitro and in lens epithelial cells. FASEB J. 20 (2006) 2645-2647
65. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
66. Reynaert N.L., van der Vliet A., Guala A.S., McGovern T., Hristova M., Pantano C., Heintz N.H., Heim J., Ho Y.-S., Matthews d.E., Wouters E.F.M., and Janseen-Heininger Y.M.W. Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory κB kinase. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10386-10391
67. Pan S., and Berk B.C. Glutathiolation regulates tumor necrosis factor-α-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ. Res. 100 (2007) 213-219
68. Wang J., Tekle E., Outrahim H., Mieyal J.J., Stadtman E.R., and Chock P.B. Stable and controllable RNA interference: investigating the physiological function of glutathionylated actin. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5103-5106
69. Qanungo S., Starke D.W., Pai H.V., Mieyal J.J., and Nieminen A.L. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFκB. J. Biol. Chem. 228 (2007) 18427-18436
70. Yen H.C., Oberley T.D., Gairola C.G., Szweda L.I., and Clair St D.K. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch. Biochem. Biophys. 362 (1999) 59-66